ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1831

Effect of the COVID-19 Pandemic on Health Status of Fibromyalgia

Tali Sahar1, Amir Minerbi2, maria Verner1, sabrina Mitrovic3, yoram Shir1, Gabrielle Page4 and mary-ann fitzcharles1, 1McGill University, Montreal, QC, Canada, 2Rambam Health Campus, Haifa, Israel, 3McGill University, Montréal-Ouest, QC, Canada, 4University of Montreal, Montreal, QC, Canada

Meeting: ACR Convergence 2023

Keywords: COVID-19, fibromyalgia, pain, quality of life

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1827–1839) Fibromyalgia & Other Clinical Pain Syndromes Poster

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Fibromyalgia (FM) symptoms fluctuate, with exacerbation commonly associated with stressors. The COVID-19 pandemic was a cause of prolonged stress due to factors such as restricted medical care, social isolation, actual COVID infection, and changes in activity or work status. Worsening of health status in FM could be anticipated. To understand the impact of the pandemic on FM patients, this survey compared health status prior to and 2 ½ years into the pandemic.

Methods: A cohort of pre-pandemic highly characterized FM patients (FM) and healthy controls (HC) completed an on-line survey in August 2022. Data included: demographic information, symptom characteristics, perception of change in health status and emotional perceptions related to the pandemic, Fibromyalgia Impact Questionnaire (FIQ), the Brief Pain Inventory (BPI), the Patient Health Questionnaire (PHQ) for anxiety and depression, the Physical Activity Self-Administered Questionnaire (AQAP), the ED-5D-5L Quality of Life Questionnaire and pandemic-related emotions using the Perceived Stress Scale (PSS). Analyses included Fischer Exact test for dichotomous variables; Wilk-Shapiro test for normality of distribution for quantitative variables; ANOVA for normally distributed variables; the non-parametric Kruskal-Wallis test for non-normally distributed variables; adjustment for multiple comparisons using Benjamini-Hochberg correction; and correlation analysis using the non-parametric Kendall Tau test. Analyses were done on IBM SPSS version 28.

Results: Participants were FM (32) and HC (21), all female, predominantly white, and with significant differences in BMI (higher in FM), living alone and work status. COVID infection occurred in FM vs HC 34% vs. 14%. Emotions related to COVID were similar for both groups (Table 1). Treatment modifications for FM were non-pharmacological vs pharmacological by 47% vs 25% respectively. FM patients generally perceived worsening of pain, but without change on questionnaire-based measurement and greater COVID perceived anxiety, but without differences for numbers screened positive for anxiety and depression on PHQ. Quality of life was significantly improved for FM, with other questionnaires measures unchanged for both groups (Table 2). Physical activity remained stable for FM but decreased for HC (Table 2). For FM, clinical measures did not correlate with demographic variables or subjective or measured change in pain, but did correlate with function, affective status and total FIQ, with no significant correlations among HC (Figure 1).

Conclusion: Contrary to expectations, FM status remained either stable or improved according to standard questionnaires, although there was a perception of increased pain. These observations could be explained by several putative explanations: 1) FM patients may have a resilience to prolonged compared to acute stressors; 2) Societal factors such as slower life pace related to the pandemic 3) as FM scored significantly higher than HC in all measures, changes during COVID pandemic may represent regression to the mean.

Supporting image 1

Table 1: Self-reported effects of COVID pandemic on personal life, health status and changes to regular medical treatment.

Supporting image 2

Table 2: Changes in clinical measures based on questionnaires for FM and HC in 2017 and in 2022.

Supporting image 3

Figure 1: Clinical measures vs. covariates for FM and HC


Disclosures: T. Sahar: None; A. Minerbi: None; m. Verner: None; s. Mitrovic: None; y. Shir: None; G. Page: None; m. fitzcharles: None.

To cite this abstract in AMA style:

Sahar T, Minerbi A, Verner m, Mitrovic s, Shir y, Page G, fitzcharles m. Effect of the COVID-19 Pandemic on Health Status of Fibromyalgia [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/effect-of-the-covid-19-pandemic-on-health-status-of-fibromyalgia/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effect-of-the-covid-19-pandemic-on-health-status-of-fibromyalgia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology